Skip to main content

Day: June 17, 2025

FLSmidth signs agreement to sell its corporate headquarters for a total net cash gain of DKK 730 million

COMPANY ANNOUNCEMENT NO. 9-2025 FLSmidth & Co. A/S17 June 2025 Copenhagen, DenmarkToday, FLSmidth has entered into a share purchase agreement with Nrep and AG Gruppen (collectively ‘the buying party’) to dispose all shares in FLSmidth’s subsidiary ‘Matr. No 2055 A/S’ owning land and buildings located on Vigerslev Allé 77 in Valby, Denmark. This announcement marks a major milestone in FLSmidth’s long history at Vigerslev Allé in Valby, Copenhagen, where the company has been based since 1899. Its iconic red-brick buildings, designed by architect Palle Suenson, was inaugurated in 1956 and today serve as the corporate headquarters. In 2022, FLSmidth announced plans to relocate to a new corporate headquarter at Havneholmen in Copenhagen, with the move currently scheduled for late 2025. The expected net cash proceeds from the sale amount...

Continue reading

W&T Announces Settlement Agreement with Majority of Surety Providers

HOUSTON, June 17, 2025 (GLOBE NEWSWIRE) — W&T Offshore, Inc. (NYSE: WTI) (“W&T” or the “Company”) today announced that it has come to a settlement agreement with two of its largest surety providers which calls for the dismissal of a previously filed lawsuit. The settlement agreement requires the surety providers to withdraw their current collateral demands, and further provides that the surety providers may not make additional collateral demands or increase premiums through December 31, 2026. Key highlights for the settlement agreement include:Dismissal of all claims by the applicable party in the lawsuit, without prejudice; Two participating surety providers, together with W&T’s other major surety provider who did not attempt to increase premiums or call for collateral, represent nearly 70% of W&T’s surety...

Continue reading

Lyell Immunopharma Announces Positive New Clinical Data Demonstrating High Rates of Durable Complete Responses from the Phase 1/2 Trial of LYL314 for the Treatment of Aggressive Large B-cell Lymphoma

LYL314 demonstrated robust clinical responses, with an 88% overall response rate and a 72% complete response rate in patients treated in the third- or later-line setting (N = 25) 71% of patients with complete response remained in complete response at ≥ 6 months Manageable safety profile appropriate for outpatient administration with no Grade ≥ 3 cytokine release syndrome and low rates of Grade ≥ 3 ICANS with rapid resolution Pivotal single-arm PiNACLE trial is underway in CAR T-naïve patients with large B-cell lymphoma treated in the third- or later-line setting Lyell to host an investor webcast at 8:00 AM ET todaySOUTH SAN FRANCISCO, Calif., June 17, 2025 (GLOBE NEWSWIRE) — Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical-stage company advancing next-generation CAR T-cell therapies for patients with cancer, today announced...

Continue reading

VEON Appoints Vitaly Shmakov as Acting General Counsel

Dubai, June 17, 2025: VEON Ltd. (Nasdaq: VEON), a global digital operator (“VEON” or the “Company”), is pleased to announce that it has appointed Vitaly Shmakov as the Acting General Counsel, based in VEON’s headquarters in the Dubai International Financial Center, effective July 1, 2025. Vitaly Shmakov is currently serving as Group Director of M&A and Strategic Transactions at VEON. Since joining the Company in 2016, he has held various roles, including Deputy General Counsel for Corporate, M&A and Strategic Transactions; Associate General Counsel; and Senior Legal Counsel. Prior to joining VEON, Vitaly was a Senior Associate for M&A and Corporate Law at Ashurst LLP, an international law firm based in London. He holds an LL.M in International Business and Trade Law from the NYU School of Law, an LL.M in Corporate &...

Continue reading

Omiyinka Doris Chooses to Step Aside from VEON General Counsel Position

Dubai, June 17, 2025: VEON Ltd. (Nasdaq: VEON; the “Company” or “VEON”), a global digital operator, today announces that Omiyinka Doris has chosen to step aside from her role as Group General Counsel of the Company effective July 1, 2025. Ms. Doris will continue as a strategic advisor to the Group Chief Executive Officer and will remain based in Amsterdam. Ms. Doris has worked with VEON for a decade, first as Deputy General Counsel, SEC/Disclosure, Finance and Governance, then as Acting Group General Counsel and most recently as the Group General Counsel and a member of the Group Executive Committee (GEC). During a time of intense geopolitical shifts, Ms. Doris played a pivotal role in steering VEON to sustained success. Ms. Doris led the successful execution of numerous key strategic initiatives across a variety of areas, including M&A,...

Continue reading

Ontex launches discreet incontinence range to European healthcare partners

Key highlights Developed to meet growing demand for dignified, high-quality and affordable continence care in both home and healthcare settings Discreet, breathable design stays virtually invisible under clothing for everyday confidence Innovations include channeled core pants for instant dryness and night pads for women with a wider back for better overnight protectionAalst, Belgium, June 17, 2025 – Ontex Group NV [EURONEXT: ONTEX], a leading international developer and producer of personal care solutions, is launching its iD Discreet range across Europe.   Meeting growing market demand Incontinence is a widespread health issue, affecting an estimated 421 million people worldwide, with numbers rising due to global population aging. To meet the increasing need for effective, dignified, and affordable continence care, Ontex is...

Continue reading

Aurora Mobile’s EngageLab Empowers Tea Beverage Brand Global Expansion with Customer Engagement Solution

SHENZHEN, China, June 17, 2025 (GLOBE NEWSWIRE) — Aurora Mobile Limited (NASDAQ: JG) (“Aurora Mobile” or the “Company”), a leading provider of customer engagement and marketing technology services in China, today announced that its subsidiary EngageLab, a leading omni-channel customer engagement platform provider, has partnered with a prominent Chinese tea beverage brand. The partnership will support the brand’s global expansion by leveraging EngageLab’s high-delivery rate AppPush notification capabilities. This Chinese new tea beverage brand has recently achieved a significant breakthrough in overseas markets by presenting Eastern tea culture through a modern lens. Built on a foundation of premium original leaf tea, the brand has strategically expanded across global markets through carefully...

Continue reading

EngageLab Empowers Tea Beverage Brand Global Expansion with Customer Engagement Solution

SINGAPORE, June 17, 2025 (GLOBE NEWSWIRE) — EngageLab, a leading omni-channel customer engagement platform provider, is proud to announce its successful partnership with a prominent Chinese tea beverage brand, supporting the company’s global expansion through EngageLab’s high-delivery rate AppPush notification capabilities. This Chinese new tea beverage brand has recently achieved a significant breakthrough in overseas markets by presenting Eastern tea culture through a modern lens. Built on a foundation of premium original leaf tea, the brand has strategically expanded across global markets through carefully tailored localization strategies. The company has successfully established thousands of stores across more than 100 countries and regions, positioning itself as a leading Chinese brand in the fresh-made tea beverage...

Continue reading

Realkredit Danmark A/S publishes new Base Prospectus for mortgage covered bonds and mortgage bonds

Realkredit Danmark A/S hereby publishes a new Base Prospectus for mortgage covered bonds and mortgage bonds. The base prospectus is available in electronic form on Realkredit Danmark’s website at www.rd.dk/Investor If you have any questions, please contact: Hella Gebhardt Ronnebaek, Chief Analyst, HGEB@rd.dkMathias Kofoed Mortensen, Senior Corporate Governance Legal Advisor, MKMO@rd.dkAttachmentRD Baseprospectus June 2025 FINAL

Continue reading

IDEX Biometrics ASA: Registration of share capital increase – 17 June 2025

Reference is made to the announcement by IDEX Biometrics ASA (the “Company”) on 11 April 2025 regarding the 11 April 2025 Extraordinary General Meeting’s resolution to carry out a subsequent offering by issuance of up to 600,000,000 new shares in the Company. Reference is also made to the announcement on 6 June 2025 regarding the subsequent offering being 8x oversubscribed, resulting in the issuance of 600,000,000 new shares at a subscription price per share of NOK 0.01, raising gross proceeds of NOK 6 million. The share capital increase has duly been registered in the Norwegian Register of Business Enterprises. Following the share capital increase, the Company’s share capital is NOK 44,316,309.99 divided into 4,431,630,999 shares, each with a nominal value of NOK 0.01. For further information contact: Kristian Flaten,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.